Lingling Xu
Nanjing University of Chinese Medicine(CN)Guizhou University(CN)Wenzhou Medical University(CN)First Affiliated Hospital of Wenzhou Medical University(CN)Third Affiliated Hospital of Southern Medical University(CN)Second Affiliated Hospital of Nanjing Medical University(CN)Southern Medical University Shenzhen Hospital(CN)Jiangsu Hengrui Medicine (China)(CN)Wuxi People's Hospital(CN)Wuhan University of Science and Technology(CN)
Publications by Year
Research Areas
Pain Mechanisms and Treatments, Diabetes Treatment and Management, Diabetes Management and Research, Pancreatic function and diabetes, Botulinum Toxin and Related Neurological Disorders
Most-Cited Works
- → Rheb/mTORC1 Signaling Promotes Kidney Fibroblast Activation and Fibrosis(2013)86 cited
- → Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome(2017)67 cited
- → Escalating dose-multiple binge methamphetamine treatment elicits neurotoxicity, altering gut microbiota and fecal metabolites in mice(2020)62 cited
- → UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury(2020)52 cited
- → Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma(2017)51 cited
- → Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves’ Ophthalmopathy(2017)51 cited